Skip to product information
1 of 1

PFIZER INTERNATIONAL CORP.

XELJANZ XR 11mg Extended-Release Tablets 30's (Upon Request)

XELJANZ XR 11mg Extended-Release Tablets 30's (Upon Request)

Therapeutic Indications:

Rheumatoid Arthritis: Tofacitinib with methotrexate (MTX) is for adults with moderate to severe RA who haven't responded to other DMARDs. Can be used alone if MTX isn't suitable.

Psoriatic Arthritis: Used with MTX for adults with active PsA who haven't responded to prior DMARD therapy.

Ankylosing Spondylitis: For adults with active AS who haven't responded to conventional therapy.

Posology and Administration:

Initiate and monitor treatment by specialist physicians.

Recommended dosage: one 11 mg extended-release tablet daily, not to be exceeded.

Stay informed and follow your healthcare provider’s advice for safe and effective treatment.

Regular price QAR 5.430,00
Regular price QAR 0,00 Sale price QAR 5.430,00
Sale Sold out
Taxes included.
Quantity

View full details